+1 888-880-9539Search News by Tag: vaccines
239 news stories found
Press Release
June 30, 2026
Creative Biolabs has expanded its custom oligosaccharide synthesis and glycan characterization services to help researchers overcome challenges in glycan synthesis, purification, structural analysis, and validation.
Read Press Release
Press Release
June 26, 2026
Creative Diagnostics announces Hantavirus Research Reagents and Products to support hantavirus research and diagnostic assay development.
Read Press Release
Press Release
June 25, 2026
The Cold Chain Biologic Temperature Monitoring Labels Market is expanding steadily as biologic manufacturers, vaccine distributors, and clinical trial operators adopt visual temperature indicators to improve shipment validation, quarantine decisions
Read Press Release
Press Release
May 28, 2026
Creative Biolabs provides payload-specific lipid formulation, analytical characterization, and scale-up support for nucleic acid and biologics delivery.
Read Press Release
Press Release
April 28, 2026
Creative Diagnostics announces the release of its Coronavirus Animal Model services to help scientists to evaluate the pathogenicity and transmissibility of Coronavirus.
Read Press Release
Press Release
April 25, 2026
Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs).
Read Press Release
Press Release
April 24, 2026
Creative Biolabs announced the launch of its enhanced lipid nanoparticle (LNP) conjugation platform—solving long‑standing challenges in nucleic acid delivery for gene therapy and RNA‑based therapeutics.
Read Press Release
Press Release
March 26, 2026
CD Bioparticles announces the launch of its new line of Alkali-Tolerant AAV Affinity Agarose Resins for the biopharmaceutical industry.
Read Press Release
Press Release
March 19, 2026
Protheragen, an ISO9001 certified supplier of specialty chemicals, offers a full portfolio of high-quality peptide intermediates, pharmaceutical intermediates, and one-stop custom intermediate solutions.
Read Press Release
Press Release
March 13, 2026
Creative Biolabs, a leading global biotechnology service provider, today detailed its expanded technological capabilities in non-vaccine mRNA applications.
Read Press Release
Press Release
January 30, 2026
Creative Biolabs expands its exosome portfolio to include non-mammalian species, boosting vaccine and drug delivery innovation.
Read Press Release
Press Release
January 21, 2026
Creative Biolabs, with the advanced liposomal delivery platform, aims to confront real bottlenecks researchers are running into right now.
Read Press Release
Press Release
January 8, 2026
Alfa Cytology provides in vitro and in vivo models of cancer and Next-Gen PBMC humanized PDX platform for tumor research and immuno-oncology studies.
Read Press Release
Press Release
November 30, 2025
Creative Biogene recently announced the release of its custom RNA services set the foundation for successful transforming cutting-edge scientific discoveries into industry-grade tools and service capabilities.
Read Press Release
Press Release
November 21, 2025
Creative Biolabs launches an advanced mRNA platform integrating in silico structural prediction and polymer-based delivery development to accelerate mRNA therapeutics and iPSC reprogramming.
Read Press Release
Press Release
November 20, 2025
Toward a cervical cancer–free future: Cancer Biology & Medicine highlights science, policy, and equity
Read Press Release
Press Release
August 30, 2025
Creative Biolabs advances glycoprotein development, supporting safer, more effective biopharmaceuticals through cutting-edge glycobiology platforms.
Read Press Release
Press Release
June 24, 2025
Creative Biolabs is at the forefront of liposome drug delivery systems to meet the expanding need for targeted delivery in research.
Read Press Release
Press Release
June 24, 2025
With mRNA's star power surging from vaccines to gene therapy to precision medicine, the biotech innovator Creative Biolabs is unlocking next-gen solutions to fast-track "impossible" medical breakthroughs.
Read Press Release
Press Release
May 21, 2025
Recently, the biotechnology service provider Creative Biolabs has unveiled a development solution focused on Lactobacillus.
Read Press Release